BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 10965879)

  • 1. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity.
    Conover CA; Bale LK; Durham SK; Powell DR
    Endocrinology; 2000 Sep; 141(9):3098-103. PubMed ID: 10965879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
    Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
    Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I.
    Imai Y; Clemmons DR
    Endocrinology; 1999 Sep; 140(9):4228-35. PubMed ID: 10465296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
    Kurihara S; Hakuno F; Takahashi S
    Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action.
    Conover CA; Clarkson JT; Bale LK
    Endocrinology; 1996 Jun; 137(6):2286-92. PubMed ID: 8641177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anchorage-independent activation of mitogen-activated protein kinase through phosphatidylinositol-3 kinase by insulin-like growth factor I.
    Suzuki K; Takahashi K
    Biochem Biophys Res Commun; 2000 May; 272(1):111-5. PubMed ID: 10872812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.
    Wilson EM; Tureckova J; Rotwein P
    Mol Biol Cell; 2004 Feb; 15(2):497-505. PubMed ID: 14595115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
    Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
    Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of phosphatidylinositol 3-kinase and p70S6 kinase blocks osteogenic protein-1 induction of alkaline phosphatase activity in fetal rat calvaria cells.
    Shoba LN; Lee JC
    J Cell Biochem; 2003 Apr; 88(6):1247-55. PubMed ID: 12647306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of IGF-binding protein-3 by mammary epithelial cells alters signaling through Akt and p70S6 kinase.
    Grill CJ; Sivaprasad U; Cohick WS
    J Mol Endocrinol; 2002 Aug; 29(1):153-62. PubMed ID: 12200236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mono- or dual-phosphorylation of akt kinase is regulated by distinct receptors that involve the common insulin receptor substrate.
    Schnyder B; Lahm H; Pittet M; Schnyder-Candrian S
    J Recept Signal Transduct Res; 2002; 22(1-4):213-28. PubMed ID: 12503617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
    Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
    Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
    Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I inhibits cell growth in the a549 non-small lung cancer cell line.
    Kodama Y; Baxter RC; Martin JL
    Am J Respir Cell Mol Biol; 2002 Sep; 27(3):336-44. PubMed ID: 12204896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells.
    Gonzalez-Robayna IJ; Falender AE; Ochsner S; Firestone GL; Richards JS
    Mol Endocrinol; 2000 Aug; 14(8):1283-300. PubMed ID: 10935551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor-alpha activation of protein kinase B in WEHI-164 cells is accompanied by increased phosphorylation of Ser473, but not Thr308.
    O'toole A; Moule SK; Lockyer PJ; Halestrap AP
    Biochem J; 2001 Oct; 359(Pt 1):119-27. PubMed ID: 11563975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative role of the phosphatidylinositol 3-kinase-Akt signaling pathway in the survival of granulosa cells.
    Westfall SD; Hendry IR; Obholz KL; Rueda BR; Davis JS
    Endocrine; 2000 Jun; 12(3):315-21. PubMed ID: 10963053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival.
    Zheng WH; Quirion R
    J Neurochem; 2004 May; 89(4):844-52. PubMed ID: 15140184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of phosphatidylinositol 3-kinase contributes to insulin-like growth factor I-mediated inhibition of pancreatic beta-cell death.
    Liu W; Chin-Chance C; Lee EJ; Lowe WL
    Endocrinology; 2002 Oct; 143(10):3802-12. PubMed ID: 12239091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3.
    Conover CA
    Endocrinology; 1991 Dec; 129(6):3259-68. PubMed ID: 1720092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.